Omar Aldalati
Omar Aldalati has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Alexander J. Chase
Morriston Hosp, Morriston Reg Cardiac Ctr, Dept Cardiol, Heol Maes Eglwys, Swansea SA6 6NL, Wales
2 shared publications - Ayush Khurana
Morriston Hosp, Morriston Reg Cardiac Ctr, Dept Cardiol, Heol Maes Eglwys, Swansea SA6 6NL, Wales
2 shared publications - David Smith
Morriston Hosp, Morriston Reg Cardiac Ctr, Dept Cardiol, Heol Maes Eglwys, Swansea SA6 6NL, Wales
2 shared publications - Ahmed Hailan
Morriston Cardiac Centre, Swansea, UK
1 shared publication - Ajay M. Shah
King's College London
1 shared publication - Andrei D. Margulescu
Department of Cardiology, Morriston Regional Cardiac Centre, Morriston Hospital, Swansea SA6 6NL, UK
1 shared publication
Latest Publications
- 5 April 2024
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 68, 23-29
Prevalence and progression of LV dysfunction and dyssynchrony in patients with new-onset LBBB post TAVR
- 5 April 2024
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 68, 23-29
Prevalence and progression of LV dysfunction and dyssynchrony in patients with new-onset LBBB post TAVR
- Open Access
- 25 March 2024
- Published by S. Karger AG in Cardiology
- Vol. 149 (5) , 487-494
Balloon Aortic Valvuloplasty with or without Percutaneous Coronary Intervention in the Transcatheter Aortic Valve Replacement Era
Introduction: The role of balloon aortic valvuloplasty (BAV) in the era of transcatheter aortic valve replacement remains a topic of debate. We sought to study the safety and feasibility of combined BAV and percutaneous coronary intervention (BAV-PCI). Methods: Between November 2009 and July 2020, all patients undergoing BAV were identified and divided into three groups: combined BAV-PCI (group A), BAV with significant unrevascularised CAD (group B), and BAV without significant CAD (group C). Procedural outcomes and 30-day and one-year mortality were compared. Results: A total of 264 patients were studied (n = 84, 93, and 87 patients in groups A, B, and C, respectively). The STS score was 10.2 ± 8, 13.3 ± 19, and 8.1 ± 7, p = 0.026, in groups A, B, and C, respectively. VARC-3 adjudicated complications were similar among groups (11%, 13%, and 5%, respectively, p = 0.168, respectively). Thirty-day and one-year mortality were 9.8% (n = 26) and 32% (n = 86) of the entire cohort. The differences among groups did not reach statistical significance. Using univariate Cox regression analysis, group B patients were at higher risk of dying compared to group A patients (HR 1.58, 95% CI: 1.11–2.25, p = 0.010). With multivariate Cox regression analysis, the predictors of mortality were STS score, cardiogenic shock, mode of presentation, and lack of subsequent definitive valve intervention. Conclusion: In high-risk patients with aortic valve stenosis, combined BAV-PCI is safe and feasible with comparable outcomes to BAV with and without significant CAD.
- 25 March 2024
- Published by S. Karger AG in Cardiology
- Vol. 149 (5) , 487-494
Open AccessBalloon Aortic Valvuloplasty with or without Percutaneous Coronary Intervention in the Transcatheter Aortic Valve Replacement Era
Introduction: The role of balloon aortic valvuloplasty (BAV) in the era of transcatheter aortic valve replacement remains a topic of debate. We sought to study the safety and feasibility of combined BAV and percutaneous coronary intervention (BAV-PCI). Methods: Between November 2009 and July 2020, all patients undergoing BAV were identified and divided into three groups: combined BAV-PCI (group A), BAV with significant unrevascularised CAD (group B), and BAV without significant CAD (group C). Procedural outcomes and 30-day and one-year mortality were compared. Results: A total of 264 patients were studied (n = 84, 93, and 87 patients in groups A, B, and C, respectively). The STS score was 10.2 ± 8, 13.3 ± 19, and 8.1 ± 7, p = 0.026, in groups A, B, and C, respectively. VARC-3 adjudicated complications were similar among groups (11%, 13%, and 5%, respectively, p = 0.168, respectively). Thirty-day and one-year mortality were 9.8% (n = 26) and 32% (n = 86) of the entire cohort. The differences among groups did not reach statistical significance. Using univariate Cox regression analysis, group B patients were at higher risk of dying compared to group A patients (HR 1.58, 95% CI: 1.11–2.25, p = 0.010). With multivariate Cox regression analysis, the predictors of mortality were STS score, cardiogenic shock, mode of presentation, and lack of subsequent definitive valve intervention. Conclusion: In high-risk patients with aortic valve stenosis, combined BAV-PCI is safe and feasible with comparable outcomes to BAV with and without significant CAD.
- Open Access
The Validation of Non-Invasive Pressure-Volume Loop Indices in Severe Aortic Stenosis
Background: Studies utilizing invasive pressure-volume loops offer valuable insights into left ventricular (LV) contractility, yet their availability remains limited. Conversely, non-invasive indices are accessible and reproducible; however, their validation in aortic stenosis (AS) is lacking. We sought to validate the non-invasive indices of PVL studies in a group of symptomatic severe AS. Methods: We recruited patients with symptomatic severe AS admitted for trans-catheter aortic valve replacement (TAVR) to undergo invasive PVL studies. Non-invasive PVL indices were measured with three-dimensional (3D) echocardiography with a pre-specified protocol. The agreement between invasive and non-invasive calculation methods were assessed. Results: Eleven patients (11) were recruited for this pilot study. The non-invasive end-systolic pressure-volume relationship (ESPVR) Kelly’s method (Ees (sb) = 0.9 × systolic blood pressure/end-systolic volume (ESV)) had the best agreement with invasive ESPVR (limits of agreement - 1.7 to 2.1 with a percentage error of 24%, one sample T-test p =0.504). Systolic blood pressure, as measured by the brachial blood pressure cuff, had the best agreement with end-systolic pressure in severe aortic stenosis (limits of agreement −60 to 60 with a percentage error of 3%, one sample T-test p =0.959). Conclusion: Measurement of the single-beat estimate of ventricular elastance (Ees (sb) ) is possible in patients with severe aortic stenosis. Kelly’s method (Ees (sb) = 0.9 × SBP /ESV) has the best agreement with the invasive measurement of left ventricular elastance (Ees). Systolic blood pressure, as measured by the brachial blood pressure cuff, has the best agreement with end-systolic pressure in severe aortic stenosis.
Open AccessThe Validation of Non-Invasive Pressure-Volume Loop Indices in Severe Aortic Stenosis
Background: Studies utilizing invasive pressure-volume loops offer valuable insights into left ventricular (LV) contractility, yet their availability remains limited. Conversely, non-invasive indices are accessible and reproducible; however, their validation in aortic stenosis (AS) is lacking. We sought to validate the non-invasive indices of PVL studies in a group of symptomatic severe AS. Methods: We recruited patients with symptomatic severe AS admitted for trans-catheter aortic valve replacement (TAVR) to undergo invasive PVL studies. Non-invasive PVL indices were measured with three-dimensional (3D) echocardiography with a pre-specified protocol. The agreement between invasive and non-invasive calculation methods were assessed. Results: Eleven patients (11) were recruited for this pilot study. The non-invasive end-systolic pressure-volume relationship (ESPVR) Kelly’s method (Ees (sb) = 0.9 × systolic blood pressure/end-systolic volume (ESV)) had the best agreement with invasive ESPVR (limits of agreement - 1.7 to 2.1 with a percentage error of 24%, one sample T-test p =0.504). Systolic blood pressure, as measured by the brachial blood pressure cuff, had the best agreement with end-systolic pressure in severe aortic stenosis (limits of agreement −60 to 60 with a percentage error of 3%, one sample T-test p =0.959). Conclusion: Measurement of the single-beat estimate of ventricular elastance (Ees (sb) ) is possible in patients with severe aortic stenosis. Kelly’s method (Ees (sb) = 0.9 × SBP /ESV) has the best agreement with the invasive measurement of left ventricular elastance (Ees). Systolic blood pressure, as measured by the brachial blood pressure cuff, has the best agreement with end-systolic pressure in severe aortic stenosis.
- Open Access
- 24 October 2023
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 96 (1152) , 20230296
Computed tomography defined femoral artery plaque composition predicts vascular complications during transcatheter aortic valve implantation
Objective: Vascular and bleeding complications after transcatheter aortic valve implantation (TAVI) are common and lead to increased morbidity and mortality. Analysis of plaque at the arterial access site may improve prediction of complications. Methods: We investigated the association between demographic and procedural risk factors for Valve Academic Research Consortium (VARC-3) vascular complications in patients undergoing transfemoral TAVI with use of a vascular closure device (ProGlide® or MANTA®) in this retrospective cohort study. The ability of pre-procedure femoral CT angiography to predict complications was investigated including a novel method of quantifying plaque composition of the common femoral artery using plaque maps created with patient specific X-ray attenuation cut-offs. Results: 23 vascular complications occurred in the 299 patients in the study group (7.7%). There were no demographic risk factors associated with vascular complications and no statistical difference between use of closure device (ProGlide®vs MANTA®) and vascular complications. Vascular complications after TAVI were associated with sheath size (OR 1.36, 95% CI 1.08–1.76, P 0.01) and strongly associated with CT-derived necrotic core volume in the common femoral artery of the procedural side (OR 17.49, 95% CI 1.21–226.60, P 0.03). Conclusion: Plaque map analysis of the common femoral artery by CT angiography reveals patients with greater necrotic core are at increased risk of VARC-3 vascular complications. Advances in knowledge: The novel measurement of necrotic core volume in the common femoral artery on the procedural side by CT analysis was associated with post-TAVI vascular complications, which can be used to highlight increased risk.
- 24 October 2023
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 96 (1152) , 20230296
Open AccessComputed tomography defined femoral artery plaque composition predicts vascular complications during transcatheter aortic valve implantation
Objective: Vascular and bleeding complications after transcatheter aortic valve implantation (TAVI) are common and lead to increased morbidity and mortality. Analysis of plaque at the arterial access site may improve prediction of complications. Methods: We investigated the association between demographic and procedural risk factors for Valve Academic Research Consortium (VARC-3) vascular complications in patients undergoing transfemoral TAVI with use of a vascular closure device (ProGlide® or MANTA®) in this retrospective cohort study. The ability of pre-procedure femoral CT angiography to predict complications was investigated including a novel method of quantifying plaque composition of the common femoral artery using plaque maps created with patient specific X-ray attenuation cut-offs. Results: 23 vascular complications occurred in the 299 patients in the study group (7.7%). There were no demographic risk factors associated with vascular complications and no statistical difference between use of closure device (ProGlide®vs MANTA®) and vascular complications. Vascular complications after TAVI were associated with sheath size (OR 1.36, 95% CI 1.08–1.76, P 0.01) and strongly associated with CT-derived necrotic core volume in the common femoral artery of the procedural side (OR 17.49, 95% CI 1.21–226.60, P 0.03). Conclusion: Plaque map analysis of the common femoral artery by CT angiography reveals patients with greater necrotic core are at increased risk of VARC-3 vascular complications. Advances in knowledge: The novel measurement of necrotic core volume in the common femoral artery on the procedural side by CT analysis was associated with post-TAVI vascular complications, which can be used to highlight increased risk.